A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Availity to Acquire Utilization Management Solution and Business Unit from Olive

Game-changing investment in transformative artificial intelligence technology aligns with Availity’s vision for intelligent and fully automated authorizations between health plans and providers

What To Know

  • “We saw a clear opportunity to acquire an automated, digital solution to one of the costliest and most manually driven workflows in healthcare—authorizations,” said Russ Thomas, CEO of Availity.
  • As a result, payers and providers can enjoy the benefits of lower administrative and medical costs, improved patient access and experience, and clinical data for making enhanced and strategic business decisions.

Availity, one of the nation’s largest real-time health information networks, announced a definitive agreement to acquire the utilization management solution and business unit from healthcare automation company Olive AI, Inc. This transaction also includes assuming the commercial contract with Olive’s current utilization management customers and hiring key associates dedicated to the utilization management business.

The acquisition strengthens Availity’s existing strategy to deliver an automated solution for end-to-end authorization transactions, which today remains driven largely by expensive, resource-intensive manual processes.

“We saw a clear opportunity to acquire an automated, digital solution to one of the costliest and most manually driven workflows in healthcare—authorizations,” said Russ Thomas, CEO of Availity. “This technology perfectly aligns with Availity’s vision of delivering omni-channel, multi-payer solutions to a fragmented healthcare data ecosystem. This game-changing solution will help our provider and health plan customers overcome the common barriers to ensuring timely care delivery, resource allocation, and patient satisfaction.”

Authorizations were created to optimize care paths and manage costs. However, Availity’s market research indicates that payers and providers collectively spend up to $13 billion every year managing an administrative process widely blamed for care delays, patient dissatisfaction, staff burnout, and friction between payers and providers.

To date, automation of authorizations has been difficult because they require both administrative and clinical data, which are often stored in siloed information systems and in non-standardized formats that require manual intervention to bring together. Availity’s AI auth solution leverages automation capabilities and Natural Language Processing (NLP) to streamline authorizations workflow, including:

  • Importing and structuring payers’ medical policies to automatically approve authorizations based on the codified medical policies.
  • Front-end capabilities that enable providers to simplify authorizations workflow.
  • Clinical data collection is automated and standardized, eliminating the multiple steps and handoffs in a manual workflow.
  • Reducing authorization approval time from days to seconds.

As a result, payers and providers can enjoy the benefits of lower administrative and medical costs, improved patient access and experience, and clinical data for making enhanced and strategic business decisions.

Availity Authorizations at HIMSS23

Learn more about the vision behind Availity’s AI auth solution at HIMSS23, April 17-21, in Chicago. Visit Availity at Booth 8336 or Meeting Place MP2284.

Transaction Details

The transaction is subject to customary closing conditions and is expected to be completed in the coming weeks. Additional details regarding the transaction were not disclosed.

SourceAvaility
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.
SABIC advises the project was initiated together with the dialysis department at Jessa Hospital, one of the largest non-university medical cluster in the Limburg region of Flanders, Belgium.

By using this website you agree to accept Medical Device News Magazine Privacy Policy